Vimpat
NDC 0131-1810, lacosamide, injection, from UCB, Inc..
- Product NDC
- 0131-1810
- Status
- Listed
- Labeler
- UCB, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022254
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/0131-1810 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0131-1810-67 | 00131181067 | 10 VIAL, GLASS in 1 CARTON (0131-1810-67) / 20 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9e79b42c-38a3-4b2c-a196-a5a1948250e2
Use it
Look up 0131-1810 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0131-1810 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0131-1810. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.